Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies

Journal of Comparative Neurology

Volumn 370, Issue 2, 1996, Pages 203-230

  Kordower, Jeffrey H ^a   Rosenstein, Jeffrey M ^b   Collier, Timothy J ^a   Burke, Melanie A ^a   Chen, Er Yun ^a   Li, Jing Min ^a   Martel, Leena ^a   Levey, Allan E ^c   Mufson, Elliott J ^a   Freeman, Thomas B ^d   Olanow, C Warren ^e  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

dopamine; neurodegenerative diseases; regeneration; striatum; transplantation

Indexed keywords

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN TRANSPLANTATION; CASE REPORT; CELL METABOLISM; CELL ULTRASTRUCTURE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; ENZYME ACTIVITY; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMAN; MALE; NERVE CELL GROWTH; NERVE FIBER GROWTH; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTRON TRANSPORT COMPLEX IV; EVALUATION STUDIES; FETAL TISSUE TRANSPLANTATION; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, ELECTRON; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 8944230650     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19960624)370:2<203::AID-CNE6>3.0.CO;2-6     Document Type: Article

References (106)

1. Abercrombie, M. (1946) Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247.
2. Annett, L.E., F.L. Martel, D.C. Rogers, R.M. Ridley, H.F. Baker, and S.B. Dunnett (1994) Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 125:228-246.
3. Anton, R., J.H. Kordower, J.S. Manaster, D.J. Kane, S. Rabizadeh, N.T. Maidment, S.B. Schueler, G. Yang, S. Rabizadeh, R.H. Edwards, C.H. Markham, and D.E. Bredesen (1994) Neural-targeted gene therapy for rodent and primate hemiparkinsomsm. Exp. Neurol. 127:199-206.
4. Arbuthnott, G., S.D. Dunnett, and N. MacLeod (1985) Electrophysiologkal properties of single units indopamine-rich mesencephalic transplants in rat brain. Neurosci. Lett. 57:205-210.
5. Bakay, R.A.E., D.L. Barrow, M.S. Fiandaca, P.M. Iuvone, A. Schiff, and D.C. Collins (1987) Biochemical and behavioral correction of MPTP-like syndrome by fetal cell transplantation. Ann. N.Y. Acad. Sci. 495:623-640.
6. Bankiewicz, K.S., R.J. Plunkett, I.J. Kopin, D.M. Jacobowitz, W.T. London, and E.H. Oldfield (1988) Transient behavioral recovery in hemiparkinsonian monkeys after adrenal medullary autografts. Prog. Brain Res. 78:543-549.
7. Bankiewicz, K.S., R.J. Plunkett, D.M. Jacobowitz, L. Porrino, U. di Porzio, W.T. London, I.J. Kopin, and E.H. Oldfield (1990) The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J. Neurosurg. 7:231-244.
8. Bernheimer, H., W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger (1973) Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20:415-455.
9. Bing, G., M.F.D. Notter, J.T. Hansen, and D.M. Gash (1988) Comparison of adrenal medullary, carotid body, and PC-12 cell cell grafts in 6-OHDA lesioned rats. Brain Res. Bull. 20:399-408.
10. Björklund, A., and U. Stenevi (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177:555-560.
11. Björklund, A., U. Stenevi, S.B. Dunnett, and S.D. Iverson (1981) Functional reactivation of the deafferented neostriatum by nigral transplants. Nature. 289:497-499.
12. Bohn M.C., L. Cupit, F. Marciano, and D.M. Gash (1987) Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237:913-915.
13. Bouyer, J., D. Park, T. Joh, and V. Pickel (1984) Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302:267-275.
14. Brand, S., and P. Rakic (1984) Cytodifferentiation and synaptogenesis in the neostriatum of fetal and neonatal rhesus monkeys. Anat. Embryol. (Berl.) 169:21-34.
15. Brundin, P., and A. Björklund (1987) Survival, growth and function of dopaminergic neurons grafted to the brain. Prog. Brain Res. 71:293-308.
16. Brundin, P., R.E. Strecker, H. Widner, D.J. Clarke, O.G. Nilsson, B. Astedt, O. Lindvall, and A. Björklund (1988a) Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunologicical aspects, spontaneous and drug-induced behavior, and dopamine release. Exp. Brain Res. 70:192-208.
17. Brundin, P., R.E. Strecker, D.J. Clarke, H. Widner, O.G. Nilsson, B. Astedt, O. Lindvall, and A. Björklund (1988b) Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease? Prog. Brain Res. Volume 78:441-448.
18. Burke, M.A., W.C. Mobley, J. Cho, S.J. Wiegand, R.M. Lindsay, E.J. Mufson, and J.H. Kordower (1994) Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Exp. Neurol. 130:178-195.
19. Cerruti, C., D.M. Walther, M.J. Kuhar, and G.R. Uhl (1993) Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Mol. Brain Res. 18:181-186.
20. Ciliax, B.J., C. Heilman, L.L. Demchyshyn, Z.B. Pristupa, E. Ince, S.M. Hersch, H.B. Niznik, and A.I. Levey (1995) The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15:1714-1723.
21. Clarke, D.J., P. Brundin, R. Strecker, O. Nilsson, A. Björklund, and O. Lendvall (1988) Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73:115-126.
22. Collier, T.J., and J.H. Kordower (1994) Fetal nigral transplants for Parkinson's disease: a preclinical and clinical prospectus. In W.C. Koller and G. Paulson (eds): Therapeutic Approaches to Parkinson's Disease. pp. 403-421.
23. Collier, T.J., J.D. Elsworth, J.R. Taylor, R.H. Roth, D.E. Redmond, Jr., and J.R. Sladek, Jr. Metabolic capacity of the fetal nigral grafts and the implanted striatum in MPTP-treated monkeys. in review.
24. Duan, W.M., H. Widner, A. Björklund, and P. Brundin (1993) Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: Will the second graft be rejected? Neuroscience 57:261-274.
25. Dunnett, S.B., A. Björklund, U. Stenevi, and S.D. Iverson (1981) Behavioral recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway I. unilateral lesions. Brain Res. 215:147.
26. Fenichel, G.M., and M. Bazelon (1968) Studies on neuromelanin. II. Melanin in the brainstem of infants and children. Neurology 18:817-820.
27. Fiandaca, M.S., J.H. Kordower, J.T. Hansen, S.-S. Jiao, and D.M. Gash (1988) Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp. Neurol. 102:76-91.
28. Fine, A., S.B. Hunt, W.H. Oertel, M. Nomoto, P.N. Chong, A. Bond, C. Waters, J.A. Temlett, L. Annett, S.B. Dunnett, P. Jenner, and C.D. Marsden (1988) Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine. Prog. Brain Res. 78: 479.
29. Freed, W.J., M.J. Perlow, F. Karoum, A. Seiger, L. Olson, B. Hoffer, and R.J. Wyatt (1980) Restoration of dopamine function by grafting of fetal substantia nigra to the caudate nucleus: long term behavioral, biochemical and histological studies. Ann. Neurol. 8:510-522.
30. Freed, W.J., J.M. Morihisa, E. Spoor, B.J. Hoffer, L. Olson, A. Seiger, and R.J. Wyatt (1981) Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature 292:351-352.
31. Freed, W.J., H.E. Cannon-Spoor, and E. Krauthamer (1985) Factors influencing the efficacy of adrenal medullary and embryonic substantia nigra grafts. Neural Grafting Mammalian CNS 78:491-504.
32. Freed, W.J., U. Patel-Vaidya, and H.M. Geller (1986) Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain. Exp. Brain Res. 63:557-566.
33. Freed, C.R., R.E. Breeze, N.L. Rosenberg, S.A. Schneck, T.H. Wells, J.N. Barrett, S.T. Grafton, S.C. Huang, D. Eidelberg, and D.A. Rottenberg (1990) Transplantation of human fetal dopamine cells for Parkinson's disease. Results at one year. Arch Neurol. 47:505-512.
34. Freed, C.R., R.E. Breeze, N.L. Rosenberg, S.A. Schneck, E. Kriek, J.-X. Qi, T. Lone, Y.-B. Zhang, J. Snyder, T. Wells, L.O. Ramig, L. Thompson, J.C. Mazziotta, S.C. Huang, S.T. Grafton, D. Brooks, G. Sawle, G. Schroter, and A.A. Ansari (1992) Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327:1549.
35. Freed, C.R., R. Revay, R.A. Vaughan, E. Kriek, S. Grant, G.R. Uhl, and M.J. Kuhar (1995) Dopamine transporter-immunoreactivity in rat brain. J. Comp. Neurol. 359:340-349.
36. Freeman, T.B., and J.H. Kordower (1991) Human cadaver embryonic substantia nigra grafts: ontogeny, preoperative graft preparation and tissue storage. In O. Lindvall, A. Björklund, and H. Widner (eds): Intracerebral Transplantation in Movement Disorders. Elsevier Press, Amsterdam pp. 163-170.
37. Freeman, T.B., M.S. Spence, B.D. Boss, D.H. Spector, R.E. Strecker, C.W. Olanow, and J.H. Kordower (1991) Development of dopaminergic neurons in the human substantia nigra. Exp. Neurol. 113:344-353.
38. Freeman, T.B., P.R. Sanberg, G.M. Nauert, C. Borlongan, E.-Z. Liu, D. Barbara, B.D. Boss, D. Spector, C.W. Olanow, and J.H. Kordower (1995a) The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 4:141-154.
39. Freeman, T.B., C.W. Olanow, R.A. Hauser, G.M. Nauert, D.A. Smith, C.V. Borlongan, P.R. Sanberg, D.A. Holt, J.H. Kordower, F.J.G. Vingerhoets, B.J. Snow, D. Calne, and L. Gauger (1995b) Bilateral fetal nigral transplantation into the post-commissural putamen as a treatment for Parkinson's disease: six month follow-up. Ann. Neurol. 38:379-388.
40. Freund, T.F., J.F. Powell, and A.D. Smith (1984) Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 13:1189-1215.
41. Freund, T.F., J.P. Bolam, A. Björklund, U. Stenevi, S.B. Dunnett, J.F. Powell, and A.D. Smith (1985) Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study. J. Neurosci. 5:603-616.
42. Graybiel, A.M., and R. Moratalla (1989) Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc. Natl. Acad. Sci. U.S.A. 86:9020-9024.
43. Graybiel, A.M., E.C. Hirsch, and Y.A. Agid (1987) Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc. Natl. Acad. Sci. U.S.A. 84:303-307.
44. Graybiel, A.M., F.C. Liu, and S.B. Dunnett (1989) Intrastriatal grafts derived from fetal striatal primordia I. Phenotopy and modular organization. J. Neurosci. 9:3250-3271.
45. Graybiel, A.M., F.-C. Liu, and S.B. Dunnett (1990) Cellular reaggregation in vivo: Modular patterns in intrastriatal grafts derived from fetal striatal primordis. In S.B. Dunnett and S.J. Richards (eds): Neural Transplantation From Molecular Basis to Clinical Applications. Progress in Brain Research, Amsterdam vol. 82, pp. 401-405.
46. Hansen, J.T., J.H. Kordower, M.S. Fiandaca, M.F.D. Notter, and D.M. Gash (1988) Adrenal medullary autografts into the basal ganglia of cebus monkeys: graft viability and fine structure. Exp. Neurol. 102:65-76.
47. Harik, S.I., R.N. Kalaria, L. Andersson, P. Lundahl, and G. Perry (1990) Immunocytochemical localization of the erythroid glucose transporter: abundance on tissues with barrier functions. J. Neurosci. 10:3862-3872.
48. Hefti, F., J. Hartikka, and M. Schlumpf (1985) Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res. 348:283-288.
49. Henderson, B.T.H., C.G. Clough, R.C. Hughes, E.R. Hitchcock, and B.G. Kenny (1991) Implantation of human ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol. 48:822-827.
50. Herman, J.-P., and N.D. Abrous (1994) Dopaminergic neural grafts after fifteen years: results and perspectives. Prog. Neurobiol. 44:1-35.
51. Hitchcock, E.H., H.L. Whitwell, M. Sofroniew, and K.S. Bankiewicz (1994) Survival of TH-positive and neuromelanin-containing cells in patients with Parkinson's disease after intrastriatal grafting of fetal ventral mesencephalon. Exp. Neurol. (Abstr.) 129:3.
52. Hsu, S.M., L. Raine, and H. Fanger (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580.
53. Jaeger, C.B. (1985a) Cytoarchitectonics of substantia nigra grafts: a light and electron microscopic study of immunocytochemically identified dopaminergic neurons and fibrous astrocytes. J. Comp. Neurol. 231:121-135.
54. Jaeger, C.B. (1985b) Immunocytochemical study of PC12 cells grafted to the brain of immature rats. Exp. Brain Res. 59:615-624.
55. Johansson, M., M. Friedemann, B. Hoffer, and I. Stromberg (1995) Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol. 134:25-34.
56. Kastner, A., E.C. Hirsh, Y. Agid, and F. Javoy-Agid (1993) Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Brain Res. 606:341-345.
57. Kish, S.J., K. Shannak, and O. Hornykiewicz (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 318:876-880.
58. Kordower, J.H., M.S. Fiandaca, M.F.D. Notter, J.T. Hansen, and D.M. Gash (1990) NGF-like trophic support from peripheral nerve for grafted rhesus adrenal chromaffin cells. J. Neurosurg. 73:418.
59. Kordower, J.H., E. Cochran, R. Penn, and C. Goetz (1991) Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann. Neurol. 29:565-572.
60. Kordower, J.H., D.L. Felten, and D.M. Gash (1992) Dopaminergic transplants for Parkinson's disease. In C.W. Olanow, A. Lieberman (eds): Scientific Basis for Therapy in Parkinson's Disease. Parthenon Press, Lancs, pp. 175-224.
61. Kordower, J.H., S.B. Schueler, D. Bredesen, T.B. Freeman, and J. Sagen (1994) Neural grafting for Parkinson's disease: an evaluation of dopaminergic donor tissues. In J. Marwah, H. Teitlebaum, and H. Prasad (eds): Neural Transplantation, CNS Neuronal Injury, and Regeneration: Recent Advances. Boca Raton, FL: CRC Press, pp. 17-37.
62. Kordower, J.H., Y.-T. Liu, S. Winn, and D.F. Emerich (1995a) Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical and neurochemical analysis. Cell Transplant. 4:155-171.
63. Kordower, J.H., T.B. Freeman, B.J. Snow, F.J.G. Vingerhoets, E.J. Mufson, P.R. Sanberg, R.A. Hauser, D.A. Smith, G.M. Nauert, D.P. Perl, and C.W. Olanow (1995b) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124.
64. Krum, J.M., N.S. More, and J.M. Rosenstein (1991) Brain angiogenesis: variations in basement membrane glycoprotein immunoreactivity. Exp. Neurol. 111:152-165.
65. Langer, L.F., and A.M. Graybiel (1984) Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res. 498:344-350.
66. Lindvall. O., P. Brundin, H. Widner, S. Rehncrona, B. Gustavii, R. Frackowiak, K.L. Leenders, G. Sawle, J.C. Rothwell, C.D. Marsden, and A. Björklund (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577.
67. Lindvall, O., H. Widner, S. Rehncrona, P. Brundin, P. Odin, B. Gustavii, R. Frackowiak, K.L. Leenders, G. Sawle, J.C. Rothwell, A. Björklund, and C.D. Marsden (1992) Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165.
68. Lindvall, O., G. Sawle, H. Widner, J.C. Rothwell, A. Björklund, D. Brooks, P. Brundin, R. Frackowiak, C.D. Marsden, and P. Odin (1994) Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35:172-180.
69. McGeer, P.L., and E.G. McGeer (1975) Evidence for glutamic acid decarboxylase containing interneurons in the neostriatum. Brain Res. 91:331-335.
70. Mahalik, T.J., T. Finger, I. Stromberg, and L. Olson (1985) Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections. J. Comp. Neurol. 240:60-70.
71. Morihisa, J.M., R.K. Nakamura, W.J. Freed, M. Mishkin, and R.J. Wyatt (1984) Adrenal medulla grafts survive and exhibit catecholamine-specific fluorescence in the primate brain. Exp. Neurol. 84:643-651.
72. Mufson, E.J., G.A. Higgins, G.A., and J.H. Kordower (1991) Nerve growth factor receptor immunoreactivity in the monkey (Cebus apella) and aged human cerebellum. J. Comp. Neurol. 308:555-575.
73. Nakao, N., E.M. Frodl, W.M. Duan, H. Widner, and P. Brundin (1994) Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. U.S.A. 91:12408-12412.
74. Nakao, N., E.M. Frodl, H. Widner, E. Carlson, F.A. Eggerding, C.J. Epstein, and P. Brundin (1995) Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1:226-231.
75. Nauert, G.M., and T.B. Freeman (1994) Low-pressure aspiration abortion for obtaining embryonic and early gestational fetal tissue for research purposes. Cell Transplant. 3:147-151.
76. Nirenberg, M.J., R.A. Vaughn, G.R. Uhl, M.J. Kuhar, and V.M. Pickel (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16:436-447.
77. Nobin, A., and A. Björklund (1973) Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol. Scand. [Suppl.] 388:1-40.
78. Olanow, C.W., J.H. Kordower, and T.B. Freeman (1996) Fetal nigral transplantation for the treatment of Parkinson's disease. Trends Neurosci. 19:102-108.
79. Pakkenberg, B., A. Moller, H.J. Gundersen, A. Mouritzen-Dam, and H. Pakkenberg (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry 54:30-33.
80. Panayotacopoulou, M.T., and D.F. Swaab (1993) Development of tyrosine hydroxylase-immunoreactive neurons in the human paraventricular and supraoptic nucleus. Dev. Brain Res. 72:145-150.
81. Pardridge, W.M., R.J. Boado, and C.R. Farrell (1990) Brain-type glucose transporter (GLUT-1) is selectively located to the blood-brain barrier. J. Biol. Chem. 256:18035-18040.
82. Perlow, M.J., W.J. Freed, B.J. Hoffer, A. Seiger, L. Olson, and R.J. Wyatt (1979) Brain grafts reduce motor abnormalities produced by destruction of the nigrostriatal dopamine system. Science. 204:643-645.
83. Peschanski, M., G. Defer, J.P. N'Guyen, F. Ricolfi, J.C. Monfort, P. Remy, C. Geny, Y. Samson, P. Hantraye, and R. Jeny (1994) Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:487-499.
84. Peters, A., S.L. Palay, and H. deF. Webster (1985) The Fine Structure of the Nervous System. Philadelphia: Saunders.
85. Redmond, D.E., Jr., J.R. Sladek, Jr., R.H. Roth, T.J. Collier, A.Y. Deutch, and S.N. Haber (1986) Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1(8490):1125-1127.
86. Redmond, D.E., Jr., C. Leranth, D.D. Spencer, R. Robbins, T. Vollmer, J.H. Kim, R.H. Roth, A.J. Dwork, and F. Naftolin (1990) Fetal neural graft survival. Lancet 336:820-822.
87. Rosenstein, J.M. (1993) Developmental expression of neuron-specific inolase immunoreactivity and cytochrome oxidase activity in neocortical transplants. Exp. Neurol. 124:208-218.
88. Rosenstein, J.M. (1995) Why do neural transplants survive? An examination of some metabolic and pathological considerations in neural transplantation. Exp. Neurol. 133:1-6.
89. Rosenstein, J.M., and N.M. More (1994) Immunocytochemical expression of the blood-brain barrier glucose transporter (GLUT 1) in neural transplants and brain wounds. J. Comp. Neurol. 350:229-240.
90. Sauer, H., W. Fischer, G. Nikkhah, S.J. Wiegand, P. Brundin, R.M. Lindsay, and A. Björklund (1993) Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 626:37-44.
91. Schultzberg, M., S.B. Dunnett, A. Björklund, U. Stenevi, T. Hökfelt, G.J. Dockray, and M. Goldstein (1984) Dopamine and cholecystokinin immunoreactive neurons in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation. Neuroscience 12:17-23.
92. Shimada, S., S. Kitayama, D.M. Walther, and G.R. Uhl (1992) Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Mol. Brain Res. 13:359-362.
93. Sladek, J.R., Jr., T.C. Collier, S.N. Haber, H.H. Roth, and D.E. Redmond, Jr. (1986) Survival and growth of fetal catecholamine neurons transplanted into the primate brain. Brain Res. Bull. 17:809-818.
94. Spencer, D.D., R.J. Robbins, F. Naftolin, K.L. Marek, T. Vollmer, C. Leranth, R.H. Roth, L.H. Price, A. Gjedde, B. Bunney, K.J. Sass, J.D. Elsworth, E.L. Kier, R. Makuch, P. Hoffer, and E. Redmond, Jr. (1992) Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N. Engl. J. Med. 327:1541.
95. Sternberger, L.A. (1986) Immunocytochemistry. New York: Wiley.
96. Takayama, H.J., Ray, H.K. Raymon, A. Baird, J. Hogg, L.J. Fisher, and F.H. Gage (1995) Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1:53-58.
97. Van den Pol, A., A. Smith, and J. Powell (1985) GABA axons in synaptic contact with dopamine neurons in the substantia nigra: double immunocytochemistry with biotin peroxidase and protein A-colloidal gold. Brain Res. 348:146-154.
98. Verney, C., A. Milosevic, C. Alvarez, and B. Berger (1993) Immunocytochemical evidence of well-developed dopaminergic and noradrenergic innervations in the frontal cerebral cortex of human fetuses at midgestation. J. Comp. Neurol. 336:331-344.
99. Watson, J.R., R.E., S.J. Wiegand, R.W. Clough, and G.E. Hoffman (1986) Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7:155-159.
100. West, M.J. (1993) New stereological methods for counting neurons. Neurobiol. Aging 14:275-265.
101. Widner, H., J. Tetrud, S. Rehncrona, B. Snow, P. Brundin, B. Gustavii, A. Björklund, O. Lindvall, and J.W. Langston (1992) Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP). N. Engl. J. Med. 327:1556.
102. Wolff, J.A., L.J. Fisher, L. Xu, H.A. Jinnah, P.J. Langlais, P.M. Iuvone, K.L. O'Malley, M.B. Rosenberg, S. Shimohamai, T. Friedmann, and F.H. Gage, F.H. (1989) Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 86:9011.
103. Wong-Riley, M.T.T. (1976) Endogenous peroxidatic activity in brainstem neurons as demonstrated by their staining with diaminobenzidine in normal squirrel monkeys. Brain Res. 108:257-277.
104. Wong-Riley, M. (1979) Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171:11-28.
105. Wong-Riley, M.T.T. (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. TINS 12:94-101.
106. Yurek, D.M., T.A.W. Lu, S. Hipkins, and S.J. Wiegand (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137:105-118.